Prothena Corp Public (PRTA) Capital Expenditures (QoQ) (2012 - 2025)
Prothena Corp Public (PRTA) Capital Expenditures (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -88.37% |
| Jun 30, 2025 | 104.76% |
| Mar 31, 2025 | -2.33% |
| Dec 31, 2024 | 377.78% |
| Sep 30, 2024 | -93.71% |
| Jun 30, 2024 | 38.83% |
| Mar 31, 2024 | -93.35% |
| Dec 31, 2023 | 250.45% |
| Sep 30, 2023 | -42.67% |
| Jun 30, 2023 | 1,506.25% |
| Mar 31, 2023 | -68.21% |
| Dec 31, 2022 | 16.15% |
| Sep 30, 2022 | -19.25% |
| Jun 30, 2022 | 631.82% |
| Mar 31, 2022 | -93.10% |
| Dec 31, 2021 | 53.37% |
| Mar 31, 2021 | -5.88% |
| Dec 31, 2020 | -33.77% |
| Sep 30, 2020 | 67.39% |
| Jun 30, 2020 | 109.09% |